GLP-1 Arg 36 replacement with Ala obviously hinders affinity (IC 50 : 0.27 nM4.6 nM) and activity (EC 50 : 2.6 nM7 nM)
However, the high cost of GLP-1 receptor agonists and limited access to these therapies in certain regions may act as restraining factors
Antisense oligonucleotides and gene-silencing approaches that directly target HTT expression are under investigation, yet have shown mixed results in clinical trials, with concerns about efficacy, safety, and delivery
Researchers should look for a lot number, compound name, testing date, purity result, method name, chromatogram reference, and identity-support note
MT-II doesnt just hit one target
What is GHK-Cu studied for in laboratory research